Author:
Gałęzowski Michał,Fabritius Charles-Henry,Pesonen Ullamari,Salo Harri,Olszak-Płachta Marta,Czerwińska Klaudia,Adamczyk Justyna,Król Marcin,Prusis Peteris,Sieprawska-Lupa Magdalena,Mikulski Maciej,Kuokkanen Katja,Obuchowicz Radosław,Korjamo Timo,Jalava Niina,Nikiforuk Agnieszka,Nowak Mateusz
Reference31 articles.
1. 5-HT6 Antagonists as Potential Treatment for Cognitive Dysfunction;K G Liu;Drug Development Research,2009
2. Overview on 5-HT receptors and their role in physiology and pathology of the central nervous system;Filip M Bader;Pharmacol Rep,2009
3. 5-HT6 receptor binding sites in schizophrenia and following antipsychotic drug administration: autoradiographic studies with [125I]SB-258585;S Z East;Synapse,2002
4. Characterization of Behavioral, Signaling and Cytokine Alterations in a Rat Neurodevelopmental Model for Schizophrenia, and Their Reversal by the 5-HT6 Receptor Antagonist SB-399885;S E Shortall;Molecular Neurobiology,2018